B

E

BARRAGÁN , Eva

Last name: BARRAGÁN

First name: Eva

November 13, 2023 (v1)

Publication

Metadata-only

Impact of FLT3–ITD mutation status and its ratio in a cohort of 2901 patients undergoing upfront intensive chemotherapy: a PETHEMA registry study

Ayala, Rosa Carreño-Tarragona, Gonzalo Barragán, Eva

FLT3–ITD results in a poor prognosis in terms of overall survival (OS) and relapse-free survival (RFS) in acute myeloid leukemia (AML). However, the prognostic usefulness of the allelic ratio (AR) to select post-remission therapy remains controversial. Our study focuses on the prognostic impact of FLT3–ITD and its ratio in a series of 2901...

Uploaded on: November 25, 2023